Labcorp Holdings Inc.
LHHealthcareNASDAQDiagnostics & Research · Last scanned Oct 26, 2026
Scan Results
Daily timeframeLabcorp Holdings Inc. provides laboratory services. The $26.68B market capitalization puts LH squarely in large-cap range for its industry. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
Market Cap
$26.68B
Beta
0.85
P/E (TTM)
27.21
P/E (Fwd)
16.63
EPS (TTM)
$12.09
EPS (Fwd)
$19.78
ROE
11.7%
ROA
5.5%
Cash
$141.8M
Total Debt
$6.82B
Free CF
$892.0M
52W Change
19.3%
Annual Financials
Cash vs Debt
Where LH stands vs its 150-day and 200-day moving averages
As of the October 16, 2026 close, LH finished 13.56% above its 150-day moving average ($286.25) and 15.25% above its 200-day moving average ($282.06). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is LH overbought or oversold?
At the October 16, 2026 close, LH's RSI(14) was 73.1, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, LH has $141.8M in cash with $6.82B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $892.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 11.7% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $11.86B to $13.95B.
Labcorp Holdings Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Labcorp Holdings Inc.'s trajectory.